P Staib

Summary

Affiliation: St. Antonius-Hospital
Country: Germany

Publications

  1. pmc WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator in
    Daniel Hofmann
    West German Study Group, Ludwig Weber Str, 15b, 41061 Moenchengladbach, Germany
    Trials 14:261. 2013
  2. ncbi request reprint [Percutaneous coronary intervention in a patient with acute myeloid leukemia]
    P Staib
    Klinik für Hämatologie und Onkologie, St Antonius Hospital, Eschweiler
    Dtsch Med Wochenschr 137:1092-5. 2012

Collaborators

  • A Niedeggen
  • Daniel Hofmann
  • Timo Schinkoethe
  • Nadia Harbeck
  • Ronald E Kates
  • Ulrike Nitz
  • Oleg Gluz

Detail Information

Publications2

  1. pmc WSG ADAPT - adjuvant dynamic marker-adjusted personalized therapy trial optimizing risk assessment and therapy response prediction in early breast cancer: study protocol for a prospective, multi-center, controlled, non-blinded, randomized, investigator in
    Daniel Hofmann
    West German Study Group, Ludwig Weber Str, 15b, 41061 Moenchengladbach, Germany
    Trials 14:261. 2013
    ..g., Ki-67, for therapy response under a short induction treatment in order to maximally individualize therapy and avoid unnecessary toxicity by ineffective treatment...
  2. ncbi request reprint [Percutaneous coronary intervention in a patient with acute myeloid leukemia]
    P Staib
    Klinik für Hämatologie und Onkologie, St Antonius Hospital, Eschweiler
    Dtsch Med Wochenschr 137:1092-5. 2012
    ..The general condition was reduced, a maculo-papulous exanthema of the face and upper body as well as a general lymphadenopathy were found...